SCHEMBL25880522

SCHEMBL25880522

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c5c3c3ccccc3n5c3ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c5c6ccccc6n4c53)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ALOX15 P16050 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ATM Q13315 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.34
PDE5A O76074 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
GBA1 P04062 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25880521 0.93 KMT2A (0.37) ACP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL25880531 0.88 MEN1 (0.37) ACP1L3MBTL1TSHRADORA3ALOX15
SCHEMBL25880354 0.84 HSD17B10 (0.41) L3MBTL1TSHRMEN1KMT2AKDM4E
SCHEMBL20857996 0.82 ACP1 (0.33) ACP1L3MBTL1TSHRADORA3ALOX15
SCHEMBL25881217 0.81 MEN1 (0.33) ADORA2AADORA1MEN1KMT2AATM
SCHEMBL21718243 0.80 ADORA3 (0.40) ACP1L3MBTL1TSHRADORA3ALOX15
SCHEMBL25880375 0.80 HSD17B10 (0.38) TSHRKDM4EALDH1A1HPGDHSD17B10
SCHEMBL24601529 0.79 MEN1 (0.39) ACP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL24601527 0.79 MEN1 (0.39) ACP1L3MBTL1TSHRMEN1KMT2A
SCHEMBL25880402 0.78 HSD17B10 (0.37) L3MBTL1TSHRKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 ACP1 4864/4885L3MBTL1 1282/4885TSHR 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.